Article 30 Oct 2018 New Arguments In Momenta On Standing To Appeal IPR Loss Before Filing A Biosimilar Application United States IP
Article 23 Oct 2018 Sandoz Uses Patent Dance to Limit Humira® Biosimilar Lawsuit to Two Patents For Now United States IP